Chemotherapy in Patients with Anthracycline- and Taxane-Pretreated Metastatic Breast Cancer: An Overview

Por Andreopoulou, Eleni, Sparano, Joseph A.
Publicado em 2013

Progress in adjuvant chemotherapy for breast cancer: an overview

Por Anampa, Jesus, Makower, Della, Sparano, Joseph A.
Publicado no BMC Med (2015)

Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma

Por Petrich, Adam M., Sparano, Joseph A., Parekh, Samir
Publicado em 2012

T Cell Coinhibition and Immunotherapy in Human Breast Cancer

Por Janakiram, Murali, Abadi, Yael M., Sparano, Joseph A., Zang, Xingxing
Publicado em 2012

HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families

Por Janakiram, Murali, Chinai, Jordan M, Zhao, Aimin, Sparano, Joseph A, Zang, Xingxing
Publicado no Oncoimmunology (2015)

Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC)

Por Adams, Sylvia, Goldstein, Lori J, Sparano, Joseph A, Demaria, Sandra, Badve, Sunil S
Publicado no Oncoimmunology (2015)

Pooled analysis of AIDS Malignancy Consortium (AMC) trials evaluating rituximab plus either CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin’s lymphoma

Por Barta, Stefan K, Lee, Jeannette Y, Sparano, Joseph A, Kaplan, Lawrence D, Noy, Ariela
Publicado em 2010

Pooled Analysis of Aids-Malignancy Consortium (AMC) Trials Evaluating Rituximab Plus either CHOP or Infusional EPOCH Chemotherapy in HIV-Associated Non-Hodgkin Lymphoma

Por Barta, Stefan K, Lee, Jeannette Y, Kaplan, Lawrence D, Noy, Ariela, Sparano, Joseph A
Publicado em 2011

TOP2A RNA Expression and Recurrence in Estrogen Receptor-Positive Breast Cancer

Por Sparano, Joseph A., Goldstein, Lori J., Davidson, Nancy E., Sledge, George W., Gray, Robert
Publicado no Breast Cancer Res Treat (2012)

Evaluation of serum Amphiregulin levels in breast cancer patients and cancer-free controls

Por Peterson, Esther A, Pectasides, Eirini, Shabbeer, Shabana, Wiechmann, Lisa, Sparano, Joseph A, Kenny, Paraic A
Publicado em 2013

A Phase I Trial of Oblimersen Sodium in Combination With Cisplatin and 5-Fluorouracil in Patients with Advanced Esophageal, Gastroesophageal Junction and Gastric Carcinoma

Por Raab, Rachel, Sparano, Joseph A., Ocean, Allyson J., Christos, Paul, Ramirez, Mark, Vinciguerra, Vincent, Kaubisch, Andreas
Publicado em 2010

High Expression of Class III β-Tubulin Predicts Good Response to Neoadjuvant Taxane and Doxorubicin/Cyclophosphamide-Based Chemotherapy in Estrogen Receptor–Negative Breast Cancer...

Por Wang, Yihong, Sparano, Joseph A., Fineberg, Susan, Stead, Lesley, Sunkara, Jaya, Horwitz, Susan Band, McDaid, Hayley M.
Publicado em 2012

A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast canc...

Por Li, Tianhong, Guo, Mengye, Gradishar, William J., Sparano, Joseph A., Perez, Edith A., Wang, Molin, Sledge, George W.
Publicado no Breast Cancer Res Treat (2012)

Pilot Study Evaluating the Interaction Between Paclitaxel and Protease Inhibitors in Patients with Human Immunodeficiency Virus-Associated Kaposi’s Sarcoma: An Eastern Cooperative...

Por Cianfrocca, Mary, Lee, Sandra, Von Roenn, Jamie, Rudek, Michelle A., Dezube, Bruce J., Krown, Susan E., Sparano, Joseph A.
Publicado em 2011

Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy

Por Vahdat, Linda T., Garcia, Agustin A., Vogel, Charles, Pellegrino, Christine, Lindquist, Deborah L., Iannotti, Nicholas, Gopalakrishna, Prashanth, Sparano, Joseph A.
Publicado em 2013

Concurrent Doxorubicin Plus Docetaxel Is Not More Effective Than Concurrent Doxorubicin Plus Cyclophosphamide in Operable Breast Cancer With 0 to 3 Positive Axillary Nodes: North A...

Por Goldstein, Lori J., O'Neill, Anne, Sparano, Joseph A., Perez, Edith A., Shulman, Lawrence N., Martino, Silvana, Davidson, Nancy E.
Publicado em 2008

A Phase I-II Study of Combined Blockade of the ErbB Receptor Network with Trastuzumab and Gefitinib in Patients with HER2 (ErbB2)-Overexpressing Metastatic Breast Cancer

Por Arteaga, Carlos L., O’Neill, Anne, Moulder, Stacy L., Pins, Michael, Sparano, Joseph A., Sledge, George W., Davidson, Nancy E.
Publicado em 2008

Phase II trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma

Por Niesvizky, Ruben, Ely, Scott, Mark, Tomer, Aggarwal, Sangeeta, Gabrilove, Janice L., Wright, John J., Chen-Kiang, Selina, Sparano, Joseph A.
Publicado em 2010

Caveolin-1 Mutations in Human Breast Cancer : Functional Association with Estrogen Receptor α-Positive Status

Por Li, Tianhong, Sotgia, Federica, Vuolo, Magalis A., Li, Maomi, Yang, Wan Cai, Pestell, Richard G., Sparano, Joseph A., Lisanti, Michael P.
Publicado em 2006

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies...

Por Kaplan, Lawrence D., Lee, Jeannette Y., Ambinder, Richard F., Sparano, Joseph A., Cesarman, Ethel, Chadburn, Amy, Levine, Alexandra M., Scadden, David T.
Publicado em 2005